North America Antimicrobial Coatings for Medical Devices Market is expected to reach US$ 1,429.08 million by 2028

At 13.9% CAGR, the North America Antimicrobial Coatings for Medical Devices Market is speculated to be worth US$ 1,429.08 million by 2028, says Business Market Insights   

According to Business Market Insights’ research, the North America antimicrobial coatings for medical devices market was valued at US$ 576.49 million in 2022 and is expected to reach US$ 1,429.08 million by 2028, registering a CAGR of 13.9% from 2022 to 2028. Rising use and demand of medical implants and broadening prevalence of hospital acquired infections (HAIs) are the critical factors attributed to the market expansion.               

With the increasing number of medical procedures and demand for advanced devices, the threat of high-risk infections from superbugs, such as MRSA, Clostridium difficile, and Pseudomonas aeruginosa, is also increasing. Implant-associated Infections (IAIs) due to medical implants account for an increasing number of deaths and high medical costs. For instance, in a study published in the National Library of Medicine (NLM) in 2020, entitled "Implant-Associated Infections: A Review of the Safety of Cardiac Implants," more than 30% of patients with left ventricular assist devices developed IAIs. The most frequently isolated bacteria were S. aureus (45.4%), and the least were coagulase-negative Staphylococcus (CONS) (5.2%). Enterobacteriaceae members constituted 24.6%, and P. aeruginosa was 13.7%. Approximately 5.2% of patients suffered IAIs caused by Candida species. The increasing prevalence of osteoarthritis and other conditions among consumers is leading to a surge in the knee and hip implants. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC), osteoarthritis affects over 32.5 million US adults annually. Additionally, according to the American Joint Replacement Registry 2021, approximately 2.4 million hip and knee surgeries were performed in 2021, representing an 18.3% increase in total procedural volume compared with 2020. Patients with osteosynthetic implants around the hip and knee show higher infection rates after joint arthroplasty. For instance, a study published in the National Library of Medicine (NLM) in 2019, titled "Clinically Asymptomatic Patients Show a High Bacterial Colonization Rate of Osteosynthetic Implants Around the Knee but Not the Hip," revealed that staphylococci are the most common causative agents of periprosthetic joint infections. Thus, antimicrobial coating technology appears to be the most proficient means of improving infection control in a healthcare setting. There is a wide variety of coating technologies and antimicrobial agents for medical devices and surgical implants, ensuring the disinfection of surfaces. Furthermore, the increasing number of medical implant procedures complement the infection rates. For instance, according to The Center Orthopedic and Neurosurgical Care & Research, by 2030, the total number of knee replacement surgeries is projected to grow to 3.5 million procedures per year. And nearly 1/2 of American adults will develop knee osteoarthritis in at least one knee in their lifetime.

On the contrary, tedious regulatory approval of antimicrobial coating products hurdles the growth of antimicrobial coatings for medical devices market.     

Based on coating type, the North America antimicrobial coatings for medical devices market is segmented into antibacterial coatings, antiviral coatings, and others. The antibacterial coatings segment held 48.4% market share in 2022, amassing US$ 279.02 million. It is projected to garner US$ 709.20 million by 2028 to expand at 14.3% CAGR during 2022–2028.

Based on device, the North America antimicrobial coatings for medical devices market is categorized into catheters, implantable devices, surgical instruments, and other devices. The catheters segment held 32.4% market share in 2022, amassing US$ 187.03 million. It is projected to garner US$ 481.59 million by 2028 to expand at 14.6% CAGR during 2022–2028.

Based on material, the North America antimicrobial coatings for medical devices market is categorized into metallic coatings and non-metallic coatings. The metallic coatings segment held 58.3% market share in 2022, amassing US$ 336.09 million. It is projected to garner US$ 855.58 million by 2028 to expand at 14.4% CAGR during 2022–2028.

Based on application, the North America antimicrobial coatings for medical devices market is categorized into general surgery, cardiovascular, orthopedics, gynecology, dentistry, and other applications. The general surgery segment held 32.0% market share in 2022, amassing US$ 184.45 million. It is projected to garner US$ 467.89 million by 2028 to expand at 14.3% CAGR during 2022–2028.

Based on end user, the North America antimicrobial coatings for medical devices market is categorized into hospitals and clinics, diagnostic centers, ambulatory surgical centers, and others. The hospitals and clinics segment held 32.9% market share in 2022, amassing US$ 189.86 million. It is projected to garner US$ 487.61 million by 2028 to expand at 14.5% CAGR during 2022–2028.

Based on country, the North America antimicrobial coatings for medical devices market has been segmented into the US, Canada, and Mexico.  Our regional analysis states that the US captured 72.1% market share in 2022. It was assessed at US$ 415.89 million in 2022 and is likely to hit US$ 1,047.80 million by 2028, exhibiting a CAGR of 14.2% during the forecast period.  

Key players dominating the North America antimicrobial coatings for medical devices market are The Dow Chemical Company; PPG Industries, Inc.; Microban International; Sciessent LLC; Covalon Technologies Ltd.; DSM; Specialty Coating Systems Inc.; AST Products, Inc.; and Hydromer, among others.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com